Fortress Biotech
FBIO
#9332
Rank
C$63.72 M
Marketcap
$2.31
Share price
-2.94%
Change (1 day)
25.00%
Change (1 year)

P/E ratio for Fortress Biotech (FBIO)

P/E ratio as of November 2024 (TTM): -0.1529

According to Fortress Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.152919. At the end of 2022 the company had a P/E ratio of -0.9305.

P/E ratio history for Fortress Biotech from 2011 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.9305-83.8%
2021-5.745.8%
2020-5.43-5.38%
2019-5.74832.98%
2018-0.6149-78.2%
2017-2.821.26%
2016-2.79-5.09%
2015-2.93-31.44%
2014-4.2860.81%
2013-2.66-23.86%
2012-3.50268.66%
2011-0.9483

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-0.0045-97.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-98.8 64,525.72%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
15.5-10,262.37%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.